Press Releases

HRH Prince Harry, The Duke of Sussex visits The Queen Elizabeth Hospital in Birmingham Scar Center

Lumenis announced that it will be supporting the first International Scar Treatment Conference in Israel.

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announced it will be the first laser company to participate in the European Burn Association’s Educational course on 'Post Burn Reconstruction' at the 17th European Burn Association (EBA) Congress, being held in Birmingham, U.K. from September 26-27, 2016.

New Clinical Results on Use of UltraPulse® in Treating Patients Suffering from Chronic Radiation Dermatitis to be presented at the French Laser Society Meeting

Lumenis Ltd., the world’s largest energy-based medical device company for aesthetic, surgical and ophthalmology applications announces the launch of Restoring Heroes Foundation, a charity that is being established to help provide the best in world class medical care for American wounded warriors.

Lumenis Ltd., the world’s largest energy-based medical device company for aesthetic, surgical and ophthalmology applications announced today that the company’s UltraPulse laser is being used in the treatment of the type of scars presented by Kim Phuc, a survivor of a Vietnam War bombing in 1972. It was chosen to be used for its effectiveness in laser scar revision therapy that is needed to penetrate deep into the thick scars.

Lumenis Ltd. (NASDAQ: LMNS), the world’s largest energy-based medical device company for aesthetic, surgical, and ophthalmic applications, announced today that two oral presentations showing the benefit of the UltraPulse® in the treatment of patients with severe burn injuries will be presented at the 16th European Burns Association (EBA) Congress, taking place September 16 -19, 2015 in Hannover, Germany.

Lumenis Ltd. (NASDAQ: LMNS), the world’s largest energy-based medical device company for aesthetic, surgical and ophthalmology applications announced today that the company supported a successful mission to treat children with burn injuries in Armenia. The mission, led by R. Rox Anderson, MD, Director of the Wellman Center for Photomedicine and Professor of Dermatology at Harvard Medical School, was designed to provide immediate access to treatment for patients in need, but also to help local medical leaders establish a sustainable burn injury care network in Armenia.